论文部分内容阅读
目的:探讨前列地尔联合慷舒灵治疗糖尿病足溃疡创面的有效性和安全性。方法:60例糖尿病足患者随机分成前列地尔(LIPO-PGE1)联合慷舒灵(含银抗菌敷料)治疗组,与常规治疗组,比较2组患者溃疡创面的愈合率和愈合时间。结果:治疗组的溃疡创面治愈率明显高于对照组(P<0.05);且平均愈合时间明显短于对照组(P<0.01)。结论:前列地尔联合慷舒灵治疗糖尿病足溃疡创面,可促进创面愈合,提高治愈率,缩短愈合天数。
Objective: To investigate the efficacy and safety of alprostadil plus gentamicin in the treatment of diabetic foot ulcer wounds. Methods: Sixty diabetic patients with diabetic foot were randomly divided into treatment group (LIPO-PGE1) and gentamicin (antimicrobial silver-containing dressing), and compared with the conventional treatment group, the healing rate and healing time of ulcer wounds were compared between the two groups. Results: The cure rate of ulcer wound in the treatment group was significantly higher than that in the control group (P <0.05), and the average healing time was significantly shorter than that in the control group (P <0.01). Conclusion: Alprostadil combined gentamicin treatment of diabetic foot ulcer wounds can promote wound healing, improve the cure rate and shorten the healing days.